How Histone Deacetylase Inhibitors Can Potentially Help in Research Focusing on a Cure for HIV
A video where one of the Principal Investigators of the Emory-CDC HIV/AIDS Clinical Trials Unit, Dr. Jeffrey Lennox, is explaining the process by which a class of medication called histone deacetylase inhibitors can potentially help lead to a cure for HIV and how studies conducted worldwide, including at Emory University, are investigating the use of this medication for such purpose.
The Toll of HIV/AIDS on the African American Community
HIV/AIDS has a disproportionate impact on the African American community. In this video Emory's Drenna Waldrop-Valverde, PhD, describes the situation in the United States as well as a new grant that will further research into the field. Waldrop-Valverde is an Associate Professor in the Nell Hodgson Woodruff School of Nursing as well as an investigate with Emory's Center for AIDS Research (CFAR).
Recent News »
Nov. 9, 2018
Public Health researchers estimate impact and efficiency of PrEP for adult and adolescent MSM in the United States
Oct. 25, 2018
Oct. 19, 2018
Emory among Gilead COMPASS InitiativeTM coordinating centers with available trainings and grant funding opportunities
Oct. 15, 2018
July 24, 2018
March 21, 2018
Jan. 10, 2018
Nov. 28, 2017
Oct. 12, 2017